Inside Precision Medicine December 5, 2022
Continuous glucose monitoring (CGM) can not only the track blood sugar of people with diabetes but also identify those at risk of the condition when combined with artificial intelligence.
Research showed just 12 hours of glucose profiles provided the predictive model with enough information to distinguish diabetic, prediabetic, and healthy individuals.
The tool could be used for monitoring and early screening of diabetes, particularly in scenarios involving remote or virtual care, and give care teams the chance to reverse the course of disease.
The findings were presented at the NeurIPS 2022 thirty-sixth Conference on Neural Information Processing Systems in New Orleans, Louisiana.
‘We were most surprised by our machine learning model’s ability to make accurate assessments on such...
Today's Sponsors
Today's Sponsor